NASDAQ: SGHTSight Sciences Inc Stock Ownership - Who owns Sight Sciences?
Insider buying vs selling
Have Sight Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alison Bauerlein | Chief Financial Officer | 2025-04-02 | 19,397 | $2.31 | $44.79kSell |
| Matthew Link | Chief Commercial Officer | 2025-04-02 | 5,042 | $2.31 | $11.64kSell |
| Jeremy B. Hayden | Chief Legal Officer | 2025-04-02 | 9,395 | $2.31 | $21.69kSell |
| David Badawi | Chief Technology Officer | 2025-04-01 | 5,980 | $2.30 | $13.77kSell |
| Paul Badawi | President and CEO | 2025-04-01 | 24,174 | $2.30 | $55.67kSell |
| Manohar K. Raheja | EVP Research Development | 2025-03-13 | 10,000 | $2.60 | $26.00kBuy |
| Manohar K. Raheja | EVP Research Development | 2025-03-12 | 10,000 | $2.73 | $27.25kBuy |
| Staffan Encrantz | Director | 2025-03-12 | 243,000 | $2.77 | $673.11kBuy |
| Staffan Encrantz | Director | 2025-03-11 | 150,000 | $2.71 | $406.50kBuy |
| Staffan Encrantz | Director | 2025-03-10 | 120,000 | $2.53 | $303.60kBuy |
SGHT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SGHT insiders and whales buy or sell their stock.
SGHT Shareholders
What type of owners hold Sight Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Paul Badawi | 11.71% | 6,010,580 | $18.93M | Insider |
| Kck Ltd | 9.30% | 4,776,232 | $15.05M | Insider |
| Kck Ltd | 8.52% | 4,374,975 | $13.78M | Institution |
| D1 Capital Partners LP | 5.84% | 3,000,000 | $9.45M | Insider |
| Jesse Selnick | 5.13% | 2,632,927 | $8.29M | Insider |
| Andrew Offer | 4.59% | 2,358,224 | $7.43M | Insider |
| Ubs Group Ag | 4.57% | 2,345,102 | $7.39M | Institution |
| Blackrock Inc | 4.55% | 2,337,353 | $7.36M | Institution |
| Long Focus Capital Management LLC | 4.36% | 2,238,632 | $7.05M | Institution |
| David Badawi | 3.58% | 1,836,704 | $5.79M | Insider |
SGHT vs Medical Device Stocks
Sight Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.